Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
melinta therapeutics
3
×
national blog main
new york blog main
san diego blog main
san diego top stories
startups
3
×
biogen
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
ipo
national
national top stories
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
medicines
3
×
bio
covid
ipo
roundup
acquisitions
activity
announced
approvals
bacteria
biogen
biopharma
business
ceo
clamped
collabs
company
daniel
deal
delays
developing
disease
drug
economic
exited
fast
fda
fighting
gilead
gilead’s
help
including
infections
infectious
introduce
isn’t
launches
lot
melinta
month
Language
unset
Current search:
medicines
×
startups
×
" melinta therapeutics "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections